Ferrokin Biosciences' Series A - II Round

Ferrokin Biosciences raised a round of funding on November 24, 2009.

FerroKin BioSciences is focused on the development of medicines used to manage iron for the treatment of disease. The company is currently developing a new treatment for transfusional iron overload. I…

Articles about Ferrokin Biosciences' Series A - II Round: